{ "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 10, "pageCount": 34, "prevPage": 9, "nextPage": 11, "slideType": "kpi_dashboard", "function": "summarize", "density": "overcrowded", "nDataPoints": 6, "notes": "The slide uses a split-screen layout to compare vaccine and therapeutic development metrics.", "elementsJson": [ "headline_text", "big_number", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/10", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckJsonHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b.json", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-10", "components": [ { "bbox": { "h": 0.08, "w": 0.1, "x": 0.66, "y": 0.69 }, "kind": "metric", "text": "Q4'20", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "35dee761-67a2-48b4-9e08-315795c265e3", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.05, "x": 0.7, "y": 0.44 }, "kind": "metric", "text": "4", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5ad5eb5a-ed3b-4115-a8b3-706d1f6d7418", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.05, "x": 0.7, "y": 0.28 }, "kind": "metric", "text": "202", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "8b0eff19-0507-4e0c-ba01-28cc8e2203fa", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.1, "x": 0.2, "y": 0.69 }, "kind": "metric", "text": "Q2'21", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b6b676b5-a4db-4c3b-a479-0bad6d02c0ae", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.05, "x": 0.24, "y": 0.28 }, "kind": "metric", "text": "30", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "c457ad5b-4c19-4e4c-a9bb-c0b9c3e2df84", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.05, "x": 0.24, "y": 0.44 }, "kind": "metric", "text": "6", "attrs": null, "subkind": "big-number", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ec1457fd-71d4-42f4-9fe3-534249af16d7", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "metric", "text": "clinical trial candidates: 202", "attrs": null, "subkind": "primary", "toolName": "Quantification", "toolSlug": "quantification", "confidence": null, "componentId": "019dd951-fefb-728e-ad95-78dd39e9586e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.2, "x": 0.62, "y": 0.78 }, "kind": "paragraph", "text": "expected broader availability", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "0e1be9dc-27cd-41c8-a260-687da7363953", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.28, "x": 0.58, "y": 0.53 }, "kind": "paragraph", "text": "key candidates currently under EUA in select countries; ensuring broad clinical trials, safety and efficacy key for further approvals", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "1fd4eb9e-5e78-4777-99e3-7209429d9784", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.26, "x": 0.12, "y": 0.78 }, "kind": "paragraph", "text": "expected start of broader distribution (beyond targeted population segments) in the best-case scenario", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "45d361ed-dd3a-4c3f-906e-4ad654e7a02b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.26, "x": 0.12, "y": 0.53 }, "kind": "paragraph", "text": "candidates currently in Phase III; in race for EUA starting Q4'20, contingent on safety and efficacy profiles", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "c0ebe2af-1cba-48e7-9c53-652636d42f04", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.2, "x": 0.15, "y": 0.37 }, "kind": "paragraph", "text": "candidates currently in clinical trials", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "dec85650-f0b7-4862-ab5b-fcbf0b2eb709", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.2, "x": 0.62, "y": 0.37 }, "kind": "paragraph", "text": "candidates currently in clinical trials", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "fc98a501-3c87-4732-b026-639705f9ad99", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.1, "w": 0.9, "x": 0.05, "y": 0.88 }, "kind": "source-note", "text": "1. Emergency Use Authorization... Source: FDA, WHO, Milken Institute; Company websites, BCG", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "37aa0c9a-8c9e-43ad-9fca-02f892a6a3e0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.5, "x": 0.05, "y": 0.04 }, "kind": "title", "text": "Vaccines & Therapeutics | Summary snapshot", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "35bd2167-4495-4931-8bac-823a2d878767", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [ { "name": "Action Titles", "slug": "action-titles", "agent": "Architect", "layer": "slide", "matchId": "019dd95a-163f-72bd-8a09-037c4966b144", "evidence": "Sub-section Summary snapshot acts as a contents header.", "confidence": 60 } ], "frameworks": [], "arcBeats": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 14, "from": 4, "beatId": "019dd95a-0702-74a3-87e3-b9ab3fe072a9", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Facts (What)", "beatSlug": "triple-take-the-facts-what", "evidence": "Snapshot, epidemic curves, vaccine pipeline, timelines", "position": 1, "confidence": 65, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "loops": [ { "to": 14, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "019dd95a-088c-724c-b30f-be0320e082a4", "evidence": "p11-12 frame unprecedented response and 12-18 month window; p13-14 detail fast movers and Q2 2021 distribution.", "position": 3, "objective": "Establish unprecedented vaccine response and timeline opportunity", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 75, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }